SLM
LSBPW

Snow Lake Management’s LakeShore Biopharma Warrants LSBPW Stock Holding History

Snow Lake Management’s Portfolio LSBPW Stock Details LSBPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-500,000
Closed -$19K – 2
2023
Q4 		$19K Hold
500,000
– – 0.02% 2
2023
Q3 		$20.6K Hold
500,000
– – 0.02% 7
2023
Q2 		$23.5K Hold
500,000
– – 0.02% 12
2023
Q1 		$77.8K Buy
+500,000
New +$75.8K 0.05% 7

Other funds holding LSBPW

AC
Athos Capital Hong Kong $282M AUM 11.4% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
VAM
Valliance Asset Management Central, Hong Kong $864M AUM 906.77% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
BP
BFAM Partners Northpoint, Hong Kong, Hong Kong $44K AUM 8.69% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $2.8B AUM 13.35% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $5.53B AUM 25.79% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $157M AUM 29.28% 1-Year Est. Return

Snow Lake Management's LSBPW Position: Q1 2024 in Review

Snow Lake Management sold out of LakeShore Biopharma Warrants (LSBPW) in Q1 2024, closing a stake of 500,000 shares — an estimated $19K sold.

Snow Lake Management first reported a position in LSBPW in Q1 2023 and held it in 4 quarters. The position peaked at $77.8K in Q1 2023. 25 funds tracked by Wall St. Rank hold LSBPW as of Q1 2024.

  • Snow Lake Management reported no remaining LakeShore Biopharma Warrants position as of Q1 2024 after selling out during the quarter.
  • Snow Lake Management sold 500,000 LakeShore Biopharma Warrants shares in Q1 2024, an estimated $19K.
  • Snow Lake Management first reported a position in LakeShore Biopharma Warrants in Q1 2023 and held it in 4 quarters.
  • Snow Lake Management's LakeShore Biopharma Warrants position peaked at $77.8K in Q1 2023.
  • 25 funds tracked by Wall St. Rank held LakeShore Biopharma Warrants as of Q1 2024.

Based on Snow Lake Management's 13F filing for Q1 2024.